TY - JOUR
T1 - Mechanisms of distal axonal degeneration in peripheral neuropathies
AU - Cashman, Christopher R.
AU - Höke, Ahmet
N1 - Funding Information:
This work was supported by the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation , NINDS ( R01 NS-43991 ), and the Foundation for Peripheral Neuropathy. The authors wish to thank Catherine Kiefe for her artistic talents and expertise in the production of figure two.
Publisher Copyright:
© 2015 Elsevier Ireland Ltd.
PY - 2015/6/2
Y1 - 2015/6/2
N2 - Peripheral neuropathy is a common complication of a variety of diseases and treatments, including diabetes, cancer chemotherapy, and infectious causes (HIV, hepatitis C, and Campylobacter jejuni). Despite the fundamental difference between these insults, peripheral neuropathy develops as a combination of just six primary mechanisms: altered metabolism, covalent modification, altered organelle function and reactive oxygen species formation, altered intracellular and inflammatory signaling, slowed axonal transport, and altered ion channel dynamics and expression. All of these pathways converge to lead to axon dysfunction and symptoms of neuropathy. The detailed mechanisms of axon degeneration itself have begun to be elucidated with studies of animal models with altered degeneration kinetics, including the slowed Wallerian degeneration (WldS) and Sarm knockout animal models. These studies have shown axonal degeneration to occur through a programmed pathway of injury signaling and cytoskeletal degradation. Insights into the common disease insults that converge on the axonal degeneration pathway promise to facilitate the development of therapeutics that may be effective against other mechanisms of neurodegeneration.
AB - Peripheral neuropathy is a common complication of a variety of diseases and treatments, including diabetes, cancer chemotherapy, and infectious causes (HIV, hepatitis C, and Campylobacter jejuni). Despite the fundamental difference between these insults, peripheral neuropathy develops as a combination of just six primary mechanisms: altered metabolism, covalent modification, altered organelle function and reactive oxygen species formation, altered intracellular and inflammatory signaling, slowed axonal transport, and altered ion channel dynamics and expression. All of these pathways converge to lead to axon dysfunction and symptoms of neuropathy. The detailed mechanisms of axon degeneration itself have begun to be elucidated with studies of animal models with altered degeneration kinetics, including the slowed Wallerian degeneration (WldS) and Sarm knockout animal models. These studies have shown axonal degeneration to occur through a programmed pathway of injury signaling and cytoskeletal degradation. Insights into the common disease insults that converge on the axonal degeneration pathway promise to facilitate the development of therapeutics that may be effective against other mechanisms of neurodegeneration.
KW - Campylobacter jejuni
KW - Chemotherapy induced peripheral neuropathy
KW - Diabetes
KW - Guillain-Barré syndrome
KW - HIV neuropathy
KW - Mechanisms of neuropathy
KW - Mitochondrial aging
KW - Peripheral neuropathy
KW - Post-infectious neuropathy
KW - Wld
UR - http://www.scopus.com/inward/record.url?scp=84930593242&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84930593242&partnerID=8YFLogxK
U2 - 10.1016/j.neulet.2015.01.048
DO - 10.1016/j.neulet.2015.01.048
M3 - Review article
C2 - 25617478
AN - SCOPUS:84930593242
SN - 0304-3940
VL - 596
SP - 33
EP - 50
JO - Neuroscience Letters
JF - Neuroscience Letters
ER -